Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia
- 1 May 1987
- journal article
- research article
- Published by Elsevier in American Journal Of Medicine
- Vol. 82 (5), 957-963
- https://doi.org/10.1016/0002-9343(87)90158-6
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1985
- Radiological demonstration of healing in Paget's disease of bone treated with APDThe British Journal of Radiology, 1985
- Cancer hypercalcemia: Recent advances in understanding and treatmentEuropean Journal of Cancer and Clinical Oncology, 1984
- The Hypercalcemia of CancerNew England Journal of Medicine, 1984
- COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIAThe Lancet, 1983
- Calcium excretion (CaE) in metastatic breast cancerBritish Journal of Surgery, 1983
- LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASESThe Lancet, 1983
- Differential Action of the Bisphosphonates (3-Amino-1-Hydroxypropylidene)-1,1-Bisphosphonate (APD) and Disodium Dichloromethylidene Bisphosphonate (Cl2MDP) on Rat Macrophage-mediated Bone Resorption In VitroJCI Insight, 1982
- Drugs Five Years LaterAnnals of Internal Medicine, 1982
- Investigation of disorders of the parathyroid glandsClinics in Endocrinology and Metabolism, 1974